Ameriprise
QTTB icon

Ameriprise’s Q32 Bio QTTB Stock Holding History

Ameriprise’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,548
Closed -$53.5K – 4170
2024
Q4 		$53.5K Buy
+15,548
New +$491K ﹤0.01% 4004
2021
Q2 		– Sell
-1,280
Closed -$217K – 3973
2021
Q1 		$217K Sell
1,280
-2,329
-65% -$490K ﹤0.01% 3687
2020
Q4 		$733K Sell
3,609
-94
-3% -$18.2K ﹤0.01% 3216
2020
Q3 		$713K Sell
3,703
-1,159
-24% -$260K ﹤0.01% 3109
2020
Q2 		$1.33M Sell
4,862
-1,634
-25% -$436K ﹤0.01% 2793
2020
Q1 		$1.82M Buy
6,496
+604
+10% +$185K ﹤0.01% 2528
2019
Q4 		$2.19M Buy
5,892
+244
+4% +$69.9K ﹤0.01% 2691
2019
Q3 		$1.84M Buy
5,648
+355
+7% +$121K ﹤0.01% 2734
2019
Q2 		$1.86M Sell
5,293
-173
-3% -$68K ﹤0.01% 2794
2019
Q1 		$2.73M Buy
5,466
+2,171
+66% +$970K ﹤0.01% 2587
2018
Q4 		$1.33M Buy
+3,295
New +$1.25M ﹤0.01% 2820

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Ameriprise's QTTB Position: Q1 2025 in Review

Ameriprise sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 15,548 shares — an estimated $53.5K sold.

Ameriprise first reported a position in QTTB in Q4 2018 and held it in 11 quarters. The position peaked at $2.73M in Q1 2019. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Ameriprise reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Ameriprise sold 15,548 Q32 Bio shares in Q1 2025, an estimated $53.5K.
  • Ameriprise first reported a position in Q32 Bio in Q4 2018 and held it in 11 quarters.
  • Ameriprise's Q32 Bio position peaked at $2.73M in Q1 2019.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.